Literature DB >> 7940688

The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation.

S V McDiarmid1, D G Farmer, J S Kuniyoshi, M Robert, A Khadavi, A Shaked, R W Busuttil.   

Abstract

Rejection continues to be a major cause of graft loss in small intestine transplantation (SIT). We have studied, by semiquantitative reverse transcriptase PCR (rtPCR), the intragraft expression of cytokines relevant to rejection in a rat model. Heterotopic SIT grafts were performed from Lewis x Brown Norway F1 donors into Lewis recipients. The isograft control was Lewis into Lewis. Five animals in each isograft and allograft group were sacrificed on POD 3, 5, 7, 8, 9, 10, 12, and 14. mRNA was isolated from portions of the terminal ileum and rtPCR performed to amplify message for interleukin-2 (IL-2), IL-2 receptor (IL-2R), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and interferon gamma (IFN-gamma). Semiquantitative analysis was performed using 32P radionuclide incorporation and scintillation counting. The results were expressed as percent activity compared with beta-actin. Histologic correlation with cytokine expression was made. On POD 3 after SIT there was no evidence of rejection by histology and all cytokines studied showed no difference between the isograft and the allograft. On POD 5 the first evidence of mild rejection was seen on histology and IL-6, IFN-gamma, TNF-alpha showed a significant up regulation in the allograft that persisted through POD 14. mRNA for IL-2 was not significantly upregulated until POD 7 and persisted until POD 14. IL-2R was constitutively expressed in both isograft and allograft and was not a reliable predictor of rejection. Histologic rejection was moderately severe by POD 7 and severe between POD 8 and 14 correlating with the increasing expression of IL-6, IFN-gamma, and TNF-alpha. In summary, we have shown that increasing expression of mRNA for IL-6, IFN-gamma, and TNF-alpha not only correlated with severity of rejection but that upregulation began early when histologic evidence of rejection first occurred.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940688

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Accumulation of donor-specific cytotoxic T cells in intestinal lymphoid tissues following intestinal transplantation.

Authors:  L P Sirinek; M S O'Dorisio; D J Dunaway
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

2.  In situ expression of cytokines in human heart allografts.

Authors:  E Van Hoffen; D Van Wichen; I Stuij; N De Jonge; C Klöpping; J Lahpor; J Van Den Tweel; F Gmelig-Meyling; R De Weger
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

3.  Anastomotic healing in a small bowel transplantation model in the rat.

Authors:  Nir Wasserberg; Andreas G Tzakis; Sergio F Santiago; Phillip Ruiz; Shashikumar K Salgar
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

4.  Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection.

Authors:  J D Wang; N Nonomura; S Takahara; B S Li; H Azuma; N Ichimaru; Y Kokado; K Matsumiya; T Miki; S Suzuki; A Okuyama
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

5.  Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1.

Authors:  K C Nadeau; H Azuma; N L Tilney
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Interleukin‑6 RNA knockdown ameliorates acute lung injury induced by intestinal ischemia reperfusion in rats by upregulating interleukin‑10 expression.

Authors:  Bing Yuan; Liu-Lin Xiong; Mu-Dong Wen; Piao Zhang; Hong-Yu Ma; Ting-Hua Wang; Yun-Hui Zhang
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

7.  Characterization of allograft rejection in an experimental model of small intestinal transplantation.

Authors:  M Hayashi; O M Martinez; S M Krams; W Burns; C O Esquivel
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.